Vitiligo and Keytruda, ASDS studies top dermatology reads for week

Study results reporting that the onset of vitiligo may be associated with clinical benefits in patients with metastatic melanoma treated with Keytruda was the most read-article of the past week on Healio.com/Dermatology.

Other widely read articles included research presented at the American Society for Dermatologic Surgery annual meeting on the use of Botox and Kybella:

Vitiligo associated with survival in patients receiving Keytruda for metastatic melanoma

The onset of vitiligo may be associated with clinical benefit in patients with metastatic melanoma who were treated with Keytruda, according to study results recently published in JAMA Dermatology.

Researchers in France conducted a prospective study of patients with metastatic melanoma from Jan. 1, 2012 to Sept. 24, 2013, at the Cancer Campus of Gustave Roussy Institute. Read more

Kybella found to be effective, satisfactory in men in analysis of phase 3 trials

CHICAGO — Men treated with Kybella in two phase 3 trials had a reduction in submental fat and were satisfied with the treatment, according to study results presented at the American Society for Dermatologic Surgery annual meeting.

Vince Bertucci

“The post-hoc analysis of the Refine-1 and Refine-2 trials showed that men got very good results, just like women did” researcher Vince Bertucci, MD, told Healio.com. Read more

Repeated Botox treatments led to progressive improvement in static glabellar lines

CHICAGO — Patients repeatedly treated with Botox over the long term displayed a progressive improvement in static glabellar lines, according to research presented at the American Society for Dermatologic Surgery annual meeting.

Alastair Carruthres

“This study amplifies the positive effects of injectable neuromodulators in long-term use in the glabella," Alastair Carruthers, FRCPC, told Healio.com. Read more

ASDS abstract session shows clinical benefits of Kybella for treating submental fat

CHICAGO — Studies focusing on different aspects of Kybella treatment for submental fat and its results were the focus of morning abstract sessions at the American Society for Dermatologic Surgery Annual Meeting.

Four of 10 abstracts presented were based on trials of Kybella (deoxycholic acid, Allergan), also known as ATX-101, which was approved by the FDA earlier this year for treatment of moderate- to-severe submental fullness. Read more

FDA approves Enstilar for topical treatment of plaque psoriasis in adults

LEO Pharma announced in a press release that Enstilar has been approved by the FDA for the topical treatment of plaque psoriasis in adults.

Enstilar (calcipotriene and betamethasone dipropionate) is an alcohol-free foam formulation in a pressurized spray can that allows for application across large areas of plaque psoriasis, according to the release. Read more